Premium
ASXL1 and CBL mutations are independently predictive of inferior survival in advanced systemic mastocytosis
Author(s) -
Pardanani Animesh D.,
Lasho Terra L.,
Finke Christy,
Zblewski Darci L.,
Abdelrahman Ramy A.,
Wassie Emnet A.,
Gangat Naseema,
Hanson Curtis A.,
Ketterling Rhett P.,
Tefferi Ayalew
Publication year - 2016
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.13865
Subject(s) - systemic mastocytosis , cancer research , mutation , medicine , oncology , immunology , genetics , biology , gene , bone marrow
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom